[Retracted] Divergent Analyses of Genetic Relatedness and Evidence-Based Assessment of Therapeutics of Staphylococcus aureus from Semi-intensive Dairy Systems

Table 4

Percentage efficacy of different treatment groups against S. aureus-based clinical mastitis.

(a)

Class of antibiotic	Bacteriostatic with bacteriostatic ()
	Antibiotic with dose rate	Alone	Sulfadimidine	Azithromycin	Oxytetracycline
Aminoglycoside	Gentamicin (G) (2.2-6 mg/kg BW)	2/5 (40%)	3/5 (60%)	2/5 (40%)	4/5 (80%)
Sulfonamide	Sulfadimidine (45 mg/kg BW) IM	2/5 (40%)	—	2/5 (40%)	3/5 (60%)
Macrolide	Azithromycin (A) (6-10 mg/kg BW)	1/5 (20%)	—	—	3/5 (60%)
Tetracycline	Oxytetracycline (O) (17 mg/kg BW)	4/5 (80%)	—	—	—

(b)

Class of antibiotic	Bactericidal with bactericidal ()
	Antibiotic with dose rate	Alone	Ciprofloxacin	Vancomycin
Cephalosporin	Cefotaxime (Ce) (10 mg/kg BW)	3/5 (60%)	3/5 (60%)	4/5 (80%)
Fluoroquinolones	Ciprofloxacin (Ci) (5-10 mg/kg body weight) (IV)	3/5 (60%)	—	4/5 (80%)
Glycopeptides	Vancomycin (V) (8-12 mg/kg BW) (IV)	3/5 (60%)	—	—